Literature DB >> 16140545

Immune suppression by tumor-specific CD4+ regulatory T-cells in cancer.

Rong-Fu Wang1.   

Abstract

Regulatory T-cells play essential roles in inducing self-tolerance by suppressing immune responses against self such as autoantigens or non-self-antigens such as tumor and pathogenic antigens. Recent studies demonstrate the existence of CD4+ regulatory T-cells at tumor sites, implying that these Treg cells may induce antigen-specific and local immune tolerance. This review will discuss the natural ligands and their potential roles of tumor-specific CD4+ regulatory T-cells in cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16140545     DOI: 10.1016/j.semcancer.2005.07.009

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  20 in total

1.  CD4+ CD25+ FoxP3+ T-cell infiltration and heme oxygenase-1 expression correlate with tumor grade in human gliomas.

Authors:  Abdeljabar El Andaloussi; Maciej S Lesniak
Journal:  J Neurooncol       Date:  2007-01-10       Impact factor: 4.130

2.  Anti-inflammatory triterpenoid blocks immune suppressive function of MDSCs and improves immune response in cancer.

Authors:  Srinivas Nagaraj; Je-In Youn; Hannah Weber; Cristina Iclozan; Lily Lu; Matthew J Cotter; Colin Meyer; Carlos R Becerra; Mayer Fishman; Scott Antonia; Michael B Sporn; Karen T Liby; Bhupendra Rawal; Ji-Hyun Lee; Dmitry I Gabrilovich
Journal:  Clin Cancer Res       Date:  2010-03-09       Impact factor: 12.531

3.  A role for T-bet-mediated tumour immune surveillance in anti-IL-17A treatment of lung cancer.

Authors:  S Reppert; I Boross; M Koslowski; Ö Türeci; S Koch; H A Lehr; S Finotto
Journal:  Nat Commun       Date:  2011-12-20       Impact factor: 14.919

4.  Enhancement of antitumor immunity by low-dose total body irradiationis associated with selectively decreasing the proportion and number of T regulatory cells.

Authors:  Rongjun Liu; Shudao Xiong; Lei Zhang; Yiwei Chu
Journal:  Cell Mol Immunol       Date:  2010-02-08       Impact factor: 11.530

5.  Mechanism of T cell tolerance induced by myeloid-derived suppressor cells.

Authors:  Srinivas Nagaraj; Adam G Schrum; Hyun-Il Cho; Esteban Celis; Dmitry I Gabrilovich
Journal:  J Immunol       Date:  2010-02-08       Impact factor: 5.422

6.  Reciprocal granzyme/perforin-mediated death of human regulatory and responder T cells is regulated by interleukin-2 (IL-2).

Authors:  Malgorzata Czystowska; Laura Strauss; Christoph Bergmann; Marta Szajnik; Hannah Rabinowich; Theresa L Whiteside
Journal:  J Mol Med (Berl)       Date:  2010-03-12       Impact factor: 4.599

Review 7.  Tregs and rethinking cancer immunotherapy.

Authors:  Tyler J Curiel
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

8.  Depletion of CD4+ CD25+ regulatory T cells inhibits local tumour growth in a mouse model of B cell lymphoma.

Authors:  I Heier; P O Hofgaard; P Brandtzaeg; F L Jahnsen; M Karlsson
Journal:  Clin Exp Immunol       Date:  2008-03-12       Impact factor: 4.330

Review 9.  Adoptive immunotherapy of cancer using CD4(+) T cells.

Authors:  Pawel Muranski; Nicholas P Restifo
Journal:  Curr Opin Immunol       Date:  2009-03-13       Impact factor: 7.486

Review 10.  Inflammation and pancreatic cancer: disease promoter and new therapeutic target.

Authors:  Shin Hamada; Atsushi Masamune; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2013-11-30       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.